HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunity markers in patients with Helicobacter pylori infection: effect of eradication.

AbstractBACKGROUND:
Helicobacter pylori is a microorganism able to stimulate a robust inflammatory and systemic immune response.
AIM:
The aim of our study was to evaluate autoimmune markers in dyspeptic patients positive for H. pylori infection compared to a control group of non-H. pylori-infected subjects. The kinetics of cryoglobulins and autoantibodies was evaluated after treatment of the infection.
PATIENTS AND METHODS:
Dyspeptic patients with active H. pylori infection and age- and sex-matched healthy H. pylori-negative controls were studied. Markers of immunity were compared, in H. pylori-infected patients before, 6 months and 1 year after the end of therapy. Results were also compared between those with and without successful eradication therapy.
RESULTS:
Eighty-six individual were entered (43 H. pylori-infected). H. pylori-infected patients had higher levels of IgG and/or IgA and/or IgM (22/43 versus 2/43). Circulating immune complexes and cryoglobulins were detected in patients more often than controls (p < .05 for both). Autoantibodies were observed in 13 patients (30% versus 5% in controls) and antithyroid antibodies in 12 (p < .04 versus controls). Lower levels of C3 and/or C4 complement fractions were observed in infected patients with respect to controls (7/43 versus 1/43; p = .014). After 1 year of follow-up, the markers of autoimmunity dramatically improved in patients eradicated for H. pylori infection compared to those in whom therapy failed. No patient developed a clinical autoimmune disorder.
CONCLUSIONS:
Additional studies are necessary to ascertain the clinical significance of the modifications of autoimmune markers in patients with H. pylori infection.
AuthorsMaria Pina Dore, Laura Fastame, Andreina Tocco, Riccardo Negrini, Giuseppe Delitala, Giuseppe Realdi
JournalHelicobacter (Helicobacter) Vol. 10 Issue 5 Pg. 391-7 (Oct 2005) ISSN: 1083-4389 [Print] England
PMID16181349 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Antigen-Antibody Complex
  • Autoantibodies
  • Biomarkers
  • Cryoglobulins
  • Immunoglobulins
Topics
  • Adult
  • Aged
  • Anti-Bacterial Agents (therapeutic use)
  • Antigen-Antibody Complex (blood)
  • Autoantibodies (blood)
  • Autoimmunity
  • Biomarkers
  • Case-Control Studies
  • Cryoglobulins (metabolism)
  • Dyspepsia (immunology, microbiology)
  • Female
  • Helicobacter Infections (drug therapy, immunology, microbiology)
  • Helicobacter pylori (drug effects)
  • Humans
  • Immunoglobulins (blood)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: